GATA Q2 REVS $17,961,452 GROUPE ATHENA, INC.

New Post Public Reply Private Reply Replies (0) Message Board
shakerzzz
GATA >>Q2 REVS $17,961,452



GROUPE ATHENA, INC. CONTINUES PACE FOR RECORD FISCAL YEAR WITH STRONG SECOND QUARTER SALES



Mumbai, MHT, India -



Mumbai, India. February 10, 2014 Groupe Athena, Inc. (Pink sheets GATA.PK) today posted their quarterly results for the three months ending December 31, 2013. The company reported revenues of $17,961,452 which is an increase of 21% when compared to the corresponding period in 2012 and represents the strongest 6 month earnings period in the company's history. Operating income for the quarter was also strong at $3, 097,791, an increase of over 26% from $2.45 million for the same period in 2012.



Net income after taxes and depreciation for the period was $2,083,606 or$.044 per share.



With regard the continued strong growth, the company's President, Ms. D Purohit stated "I can't put into words how exciting it is to see our dreams become reality. Our core business is thriving and our expansion plans are proceeding as expected. We fully expect 2014 to be a breakout year for Groupe Athena, Inc".



The company reiterates that the strong increase in operating income is due to the continued increases in gross margins and they anticipate further increases as more work is transitioned in- house. Operating margins are approaching 20%currently and management remains committed to attain  40% gross margins over the next few years.


The company's order position also remains very healthy and management expects record total revenues of at least $65 million for the current fiscal year.




Cash and cash equivalents are at record levels for the company and continue to grow and debt remains virtually non-existent.






To review the complete quarterlyreport please go to www.otcmarkets.com/stock/GATA/quoteand click on "Financials".



The Indian pharmaceutical industry is increasingly focusing on exports to the United States and Europe and GATA is well positioned to help them get their products approved by the respective governing bodies for sales in both regions. All of these are potential clients and the Company believes it has an advantage over competitors due to the facilities based in India, and their ability to deliver quick feedback to clients that could result in expedited order generation. With recent additions to equipment, the company will continue to take on additional contracts and continue to anticipate further growth.




About Groupe Athena, Inc.




Groupe Athena Inc. was incorporated in June 2008 and began operations on July 1 of that year. The company is a research and testing organization and helps various pharmaceutical and medical products and devices companies in India and Southeast Asia to get regulatory approvals and facilitate exports of their products to the United States. The Company accomplishes this by assisting clients from concept through development, providing consultation on regulatory requirements, filings and processes.


The company has a research and marketing facility in India that currently employs 18 consultants and marketing personnel and is working towards aggressively expanding its presence in the Indian pharmaceutical industry. The Company's web address is www.groupeathena.com







For more information contact:



Paul Cornell



Cornellpaul6@gmail.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stocks Jump Ahead of Critical Inflation Reports

Updated Category News Views 129

Stocks Lift as Wall Street Awaits Inflation Data Every trader's favorite game—speculation—returns as major U.S. stock benchmarks kick off Monday with some gusto. The S&P 500, Nasdaq Composite, Dow Jones Industrial Average, and Russell 2000 all saw gains in the early morning session, signaling positive vibes across the board. Numbers don't lie, folks: The S&P climbed...

Continue Reading
AutoMobility LA: Autonomous Tech's Big Leap

Updated Category News Views 61

Rolling Toward an Autonomous Future Alright, gearheads and tech buffs alike, gather 'round for a ride into the future of road travel. AutoMobility LA, a brainchild of the Los Angeles Auto Show, is revving up to give us a sneak peek into the era where cars don't just roll—they think. "The future's not about who's behind the wheel, but who's crafting the brain of the...

Continue Reading
Hyperscale Data Plans Major Stock Exchange Deal

Updated Category News Views 80

Hyperscale's Bold Move: Exchange Offer Hits the Market Man, when a company believes its market value is out of whack, you get moves like this. Hyperscale Data, strutting under ticker symbol NYSE:GPUS, is swinging for the fences with an exchange offer, aiming to mop up $50 million worth of its common stock with a sweet deal that’s sure to grab any investor's attention....

Continue Reading
Cloud Software Group's $2B Debt Offer Wraps Up

Updated Category News Views 101

Sizing Up Cloud Software Group’s Recent Maneuver Whoever thought navigating debt was a dull spectacle hasn’t kept up with Cloud Software Group's recent financial theatrics. With a $2 billion cap on the table, their cash tender offer for 9.00% Senior Secured Second Lien Notes due 2029 didn’t just happen; it paraded onto the financial stage and left a noteworthy...

Continue Reading
Chipotle's BOGO Promo Returns: Tattoos Boost Sales

Updated Category News Views 101

Chipotle's BOGO Charade: A Tattooed Affair You've got to hand it to Chipotle—they know how to turn heads and wallets with their quirky promotions. The upcoming 'Tatted Like a Chipotle Bag' offer is a prime example of how they ride the cultural zeitgeist as they gear up for another record-breaking day on Friday, November 13. And seriously, with tattoos in play, they're...

Continue Reading
Energenesis Tackles Space Anemia with ATP Boost

Updated Category News Views 84

Gearing Up for Space Medicine: Enter Energenesis With the cosmic frontier drawing investor eyes and day-to-day operations inching skyward, here comes Energenesis Biomedical (TWSE: 6657), poking its head into space medicine. This isn’t just another biotech firm looking to throw drugs at terrestrial problems. No, Energenesis shot its shot at TASTI 2026 with its...

Continue Reading
Guizhou's Mountain Conference Pushes Tourism Evolution

Updated Category News Views 28

Climbing High: Guizhou's Tourism Summit The 2026 International Conference of Mountain Tourism and Outdoor Sports in Guizhou has kicked off with a heartfelt focus on merging natural allure with modern tourism. This isn't just another gathering; it's a powerhouse of international dialogue harbored right in China's dramatic landscape. Building on Unique Natural Assets...

Continue Reading
Bybit Shines at Web Summit 2026 as AI Takes Center Stage

Updated Category News Views 95

Financial Revolution: Bybit Steals the Spotlight Ever been to a tech show where financial bigwigs mingle with code geeks? Well, that's exactly the scene unfolding at the famed Web Summit 2026, with Bybit throwing down the gauntlet as an official partner. The MEO Arena in Lisbon is buzzing more than a stock ticker on a rollercoaster day, as Bybit flaunts its wares to a...

Continue Reading
Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Updated Category News Views 97

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...

Continue Reading
NSAP's First Board Aims to Revolutionize Autism Care

Updated Category News Views 61

Out in Silicon Valley, where innovation isn’t just a buzzword, the National Society of Autism Professionals (NSAP) is stirring the pot with some serious leadership moves. Just this month, they cobbled together their inaugural board of directors—a gathering of eight experts from every corner of the autism field you can think of. They’re not playing small ball, no...

Continue Reading

Top 5 Most Recently Viewed Articles

Municipality Finance Launches EUR 25 Million Debt Offering

Updated Category News Views 148

Overview of Municipality Finance's New Notes Issuance Municipality Finance Plc has announced its latest financing initiative, issuing EUR 25 million in notes under its Medium Term Note (MTN) program. This strategic move aims to provide funding for various projects aimed at enhancing sustainability and improving public infrastructure. Details of the Notes Issued The notes...

Continue Reading
Significant Insider Stock Purchase at Nordson Raises Interest

Updated Category News Views 141

Notable Insider Transaction at Nordson Annette K Clayton, a Board Member at Nordson (NASDAQ:NDSN), has made headlines by disclosing a significant stock purchase recently through a new SEC filing. What Triggered This Purchase? According to the Form 4 filing, Clayton acquired 930 shares of Nordson stock, amounting to an impressive total of approximately $215,713. This move...

Continue Reading
Lantheus Holdings Set to Showcase Innovations at Conference

Updated Category News Views 89

Lantheus Holdings to Shine at the Upcoming Conference Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent name in the radiopharmaceutical sector, recently made waves by announcing that the CEO, Brian Markison, will take the stage at the Morgan Stanley 23rd Annual Global Healthcare Conference. The presentation is scheduled for 7:00 a.m. ET on an upcoming Tuesday, where...

Continue Reading
DeepHealth Partners with CARPL.ai for Revolutionary AI Control in Radiology

Updated Category News Views 366

DeepHealth and CARPL.ai: A Collaboration for AI Innovation DeepHealth, a wholly-owned subsidiary under the umbrella of RadNet, Inc. (NASDAQ: RDNT), is embarking on an exciting collaboration with CARPL.ai, a leader in AI orchestration. This strategic partnership aims to develop a novel AI control system tailored for clinical image interpretation to drive enhanced...

Continue Reading
Exploring the Potential of Healthcare Stocks Amid Market Growth

Updated Category News Views 181

The stock market is navigating through exciting times, with the S&P 500 recently eclipsing the significant milestone of 5,700 points. This robust performance is fueled by a dynamic shift as investors increasingly look towards emerging sectors, particularly healthcare, which is gaining momentum this earnings season. This year, we've seen an impressive trend, with over 40...

Continue Reading